State Medicaid programs must cover medication assisted treatment under a new mandatory benefit that takes effect today.

The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018 added the benefit to increase access to evidenced-based treatment for opioid use disorder for Medicaid beneficiaries.

Specifically, states must cover all forms of drugs and biologicals that the Food and Drug Administration has approved or licensed for MAT to treat OUD, the Centers for Medicare & Medicaid Services said today in a reminder notice

 

Related News Articles

Headline
The Centers for Medicare & Medicaid Services Friday released updated guidance on COVID-19 vaccination coverage and reimbursement to help Medicaid, Children…
Headline
The Centers for Medicare & Medicaid Services today approved state plan amendments allowing Tennessee and South Carolina to extend postpartum coverage from…
Headline
The Government Accountability Office today named four new members to the Medicaid and CHIP Payment and Access Commission, which advises Congress on issues…
Headline
Robust outreach and enrollment efforts, and standards and payments that ensure timely and equitable access to quality care are critical to a comprehensive…
Headline
Michigan yesterday became the second state to extend postpartum coverage from 60 days to 12 months after pregnancy for Medicaid and Children’s Health Insurance…
Headline
The Medicaid and CHIP Payment and Access Commission today approved recommendations calling on the Centers for Medicare & Medicaid Services to increase…